See What HealthDay Can Do For You
Contact Us

Generic Versions of Fosamax Approved

A popular drug to treat osteoporosis

WEDNESDAY, Feb. 6, 2008 (HealthDay News) -- The U.S. Food and Drug Administration has approved the first generic equivalents of Fosamax (alendronate sodium), Merck & Co.'s osteoporosis drug.

In a statement, the Israeli firm Teva Pharmaceutical Industries Ltd. said the FDA had approved its new drug application to market the medication in doses of 5 milligrams, 10 milligrams, 35 milligrams, 40 milligrams, and 70 milligrams. Shipment will begin immediately.

The brand-name drug had annual U.S. sales of about $1.9 billion for the period ended Sept. 30, Teva said.

New Jersey-based Barr Pharmaceuticals Inc. also announced that it had received FDA approval to produce a 70-milligram dose of generic Fosamax.

More information

The FDA has more information about this medication.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.